- $56.97m
- -$41.05m
- 27
- 99
- 46
- 58
Annual balance sheet for Avrobio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 187 | 260 | 190 | 92.6 | 98 |
| Net Total Receivables | 1.92 | 2.56 | 2.7 | 0.269 | 0 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 196 | 267 | 199 | 100 | 100 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.7 | 3.06 | 4.13 | 3.95 | 0.432 |
| Other Long Term Assets | |||||
| Total Assets | 201 | 271 | 204 | 104 | 101 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14 | 16.6 | 19.4 | 13.1 | 6.35 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.5 | 16.9 | 34.4 | 28.6 | 6.35 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 186 | 254 | 169 | 75.4 | 94.7 |
| Total Liabilities & Shareholders' Equity | 201 | 271 | 204 | 104 | 101 |
| Total Common Shares Outstanding |